Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
暂无分享,去创建一个
Qian Tao | Jie Jin | Qian Zhang | Jianming Ying | Q. Tao | J. Ying | Yichao Fan | Jie Jin | Jisheng Li | Fan Fong Poon | Ka Man Ng | Jisheng Li | K. Ng | Yichao Fan | F. Poon | Qian Zhang
[1] B. Teh,et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. , 2005, Cancer research.
[2] R. Uzzo,et al. Promoter Hypermethylation Profile of Kidney Cancer , 2004, Clinical Cancer Research.
[3] R. Berkowitz,et al. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. , 2006, Neoplasia.
[4] Q. Tao,et al. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. , 2007, Cancer letters.
[5] Jun Yu,et al. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers , 2009, British Journal of Cancer.
[6] P. Carroll,et al. Methylation of the γ-Catenin Gene is Associated With Poor Prognosis of Renal Cell Carcinoma , 2005 .
[7] J. Cheville,et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus , 2004, BJU international.
[8] A. Protopopov,et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Zabarovsky,et al. Search for unknown tumor‐antagonizing genes , 2003, Genes, chromosomes & cancer.
[10] Loren Lipworth,et al. Epidemiologic aspects of renal cell carcinoma. , 2006, Seminars in oncology.
[11] J. Califano,et al. Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer , 2004, Cancer Research.
[12] G. Ito,et al. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. , 2005, Cancer letters.
[13] Q. Tao,et al. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. , 2002, Human molecular genetics.
[14] Tamas Beothe,et al. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. , 2003, Cancer research.
[15] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[16] Yusuke Nakamura,et al. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma , 2007, Genes, chromosomes & cancer.
[17] M. Salto‐Tellez,et al. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. , 2008, Journal of hepatology.
[18] M. Toyota,et al. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma , 2006, Oncogene.
[19] Qian Tao,et al. The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors , 2005, Clinical Cancer Research.
[20] Paul Cairns,et al. Gene methylation and early detection of genitourinary cancer: the road ahead , 2007, Nature Reviews Cancer.
[21] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[22] Y. Nakamura,et al. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. , 1999, Cancer research.
[23] D. Gutmann,et al. Promoter hypermethylation of the potential tumor suppressor DAL‐1/4.1B gene in renal clear cell carcinoma , 2006, International journal of cancer.
[24] I. Zanna,et al. Loss of heterozygosity and methylation of p16 in renal cell carcinoma , 2003, Urological Research.